Amivantamab and Recombinant Human Hyaluronidase/Carboplatin/Pemetrexed Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of amivantamab and recombinant human hyaluronidase, carboplatin, and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Amivantamab and Hyaluronidase-Carboplatin-Pemetrexed - Amivantamab and Hyaluronidase-lpuj-Carboplatin-Pemetrexed - Amivantamab and Hyaluronidase-lpuj/Carboplatin/Pemetrexed - Amivantamab and Hyaluronidase/Carboplatin/Pemetrexed Regimen - Amivantamab and Recombinant Human Hyaluronidase-Carboplatin-Pemetrexed - Amivantamab and Recombinant Human Hyaluronidase/Carboplatin/Pemetrexed - Amivantamab-Hyaluronidase/Carboplatin/Pemetrexed - Carboplatin/Pemetrexed/Rybrevant Faspro - Rybrevant Faspro/Carboplatin/Pemetrexed